Lipomatous Atrial Septal Hypertrophy: A Review of Its Anatomy, Pathophysiology, Multimodality Imaging, and Relevance to Percutaneous Interventions

• Published in: Journal of the American Society of Echocardiography Vol. 29; no. 8; pp. 717 - 723
• Main Authors: Laura, Diana M., MD, Donnino, Robert, MD, Kim, Eugene E., MD, Benenstein, Ricardo, MD, Freedberg, Robin S., MD, Saric, Muhamed, MD, PhD
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.2016
• Subjects: Atrial Septum - diagnostic imaging; Atrial Septum - pathology; Atrial Septum - physiopathology; Cardiomegaly - diagnostic imaging; Cardiomegaly - pathology; Cardiomegaly - physiopathology; Cardiovascular; Diagnosis, Differential; Echocardiography - methods; Humans; Lipomatosis - diagnostic imaging; Lipomatosis - pathology; Lipomatosis - physiopathology; Lipomatous atrial septal hypertrophy; Transseptal puncture; Transesophageal echocardiography; MRI; FDG; Fluorodeoxyglucose; Brown adipose tissue; LASH; Lipomatous atrial septal hypertrophy; ICE; Transseptal puncture; CT; 3D; ASD; Computed tomography; Magnetic resonance imaging; Three-dimensional; BAT; TEE; Atrial septal defect; Intracardiac echocardiography
• ISSN: 0894-7317; 1097-6795
• DOI: 10.1016/j.echo.2016.04.014

Lipomatous atrial septal hypertrophy (LASH) is a histologically benign cardiac lesion characterized by excessive fat deposition in the region of the interatrial septum that spares the fossa ovalis. The etiology of LASH remains unclear, though it may be associated with advanced age and obesity. Because of the sparing of the fossa ovalis, LASH has a pathognomonic dumbbell shape. LASH may be mistaken for various tumors of the interatrial septum. Histologically, LASH is composed of both mature and brown (fetal) adipose tissue, but the role of brown adipose tissue remains unclear. In interventional procedures requiring access to the left atrium, LASH may interfere with transseptal puncture, as traversing the thickened area can reduce the maneuverability of catheters and devices. This may cause the needle to enter the epicardial space, causing dangerous pericardial effusions. LASH was once considered a contraindication to percutaneous device closure of atrial septal defects because of an associated increased risk for incorrect device deployment. However, careful attention to preprocedural imaging and procedural intracardiac echocardiography enable interventional cardiologists to perform procedures in patients with LASH without serious complications. In this review article, the authors describe anatomic and functional aspects of LASH, with emphasis on their roles in percutaneous interventions.